ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bacille Calmette-Guerin Vaccine Market Research Report 2026
Published Date: 2026-04-17
|
Report Code: QYRE-Auto-20C11208
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Bacille Calmette Guerin Vaccine Market Research Report 2022
BUY CHAPTERS

Global Bacille Calmette-Guerin Vaccine Market Research Report 2026

Code: QYRE-Auto-20C11208
Report
2026-04-17
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Japan BCG Lab
China National Biotec
Serum Institute of India
AJ Vaccines
Biofarma
GreenSignal Bio Pharma
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen

Bacille Calmette-Guerin Vaccine Market Size

The global Bacille Calmette-Guerin Vaccine market was valued at US$ 82.61 million in 2025 and is anticipated to reach US$ 102 million by 2032, at a CAGR of 3.1% from 2026 to 2032.

Bacille Calmette-Guerin Vaccine Market

Bacille Calmette-Guerin Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Bacille Calmette-Guerin Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Bacille Calmette-Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). Developed from a strain of weakened Mycobacterium bovis, the BCG vaccine is commonly administered to infants and children in countries where tuberculosis is prevalent. While it does not provide complete immunity, it significantly reduces the risk of severe forms of TB, such as TB meningitis and miliary tuberculosis in young children. BCG is also being researched for potential applications in treating bladder cancer and boosting immune responses in certain conditions.
The primary drivers of the Bacille Calmette-Guérin (BCG) vaccine market is the continued high prevalence of tuberculosis (TB) in many parts of the world, particularly in Asia and Africa. Increased awareness and government initiatives to control and eradicate TB contribute to demand for the vaccine. Additionally, ongoing research on the potential use of the BCG vaccine in treating other diseases, such as bladder cancer and potentially as a non-specific immune booster, is also bolstering its market demand.
A major challenge in the BCG vaccine market is supply constraints due to the limited number of manufacturers, as production requires specialized facilities and quality control measures. Additionally, the vaccine's effectiveness varies by region and is less protective in adults than in children, which affects its perception and demand in some areas. Furthermore, stringent regulatory standards and the relatively long time required for production can limit supply, especially during times of increased demand or global health crises. Asia-Pacific is the largest consumption place, with a consumption market share nearly 46% in 2023. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 36%. Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, etc. are the leaders of the industry.
This report delivers a comprehensive overview of the global Bacille Calmette-Guerin Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Bacille Calmette-Guerin Vaccine. The Bacille Calmette-Guerin Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Bacille Calmette-Guerin Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Bacille Calmette-Guerin Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Bacille Calmette-Guerin Vaccine Market Report

Report Metric Details
Report Name Bacille Calmette-Guerin Vaccine Market
Accounted market size in 2025 US$ 82.61 million
Forecasted market size in 2032 US$ 102 million
CAGR 3.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Immune Vaccine
  • Therapy Vaccine
by Application
  • Self-Procurement
  • UNICEF
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, IVAC – Institute of Vaccines and Medical Biologicals, Queen Saovabha Mem. Inst, Microgen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Bacille Calmette-Guerin Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Bacille Calmette-Guerin Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Bacille Calmette-Guerin Vaccine Market growing?

Ans: The Bacille Calmette-Guerin Vaccine Market witnessing a CAGR of 3.1% during the forecast period 2026-2032.

What is the Bacille Calmette-Guerin Vaccine Market size in 2032?

Ans: The Bacille Calmette-Guerin Vaccine Market size in 2032 will be US$ 102 million.

What is the Bacille Calmette-Guerin Vaccine Market share by region?

Ans: Asia-Pacific is the largest consumption place, with a consumption market share nearly 46% in 2023.

Who are the main players in the Bacille Calmette-Guerin Vaccine Market report?

Ans: The main players in the Bacille Calmette-Guerin Vaccine Market are Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, IVAC – Institute of Vaccines and Medical Biologicals, Queen Saovabha Mem. Inst, Microgen

What are the Application segmentation covered in the Bacille Calmette-Guerin Vaccine Market report?

Ans: The Applications covered in the Bacille Calmette-Guerin Vaccine Market report are Self-Procurement, UNICEF, Other

What are the Type segmentation covered in the Bacille Calmette-Guerin Vaccine Market report?

Ans: The Types covered in the Bacille Calmette-Guerin Vaccine Market report are Immune Vaccine, Therapy Vaccine

1 Bacille Calmette-Guerin Vaccine Market Overview
1.1 Product Definition
1.2 Bacille Calmette-Guerin Vaccine by Type
1.2.1 Global Bacille Calmette-Guerin Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Bacille Calmette-Guerin Vaccine by Application
1.3.1 Global Bacille Calmette-Guerin Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Global Bacille Calmette-Guerin Vaccine Market Size Estimates and Forecasts
1.4.1 Global Bacille Calmette-Guerin Vaccine Revenue 2021–2032
1.4.2 Global Bacille Calmette-Guerin Vaccine Sales 2021–2032
1.4.3 Global Bacille Calmette-Guerin Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Bacille Calmette-Guerin Vaccine Market Competition by Manufacturers
2.1 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Bacille Calmette-Guerin Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Bacille Calmette-Guerin Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Date of Entry into the Industry
2.8 Global Bacille Calmette-Guerin Vaccine Market Competitive Situation and Trends
2.8.1 Global Bacille Calmette-Guerin Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Bacille Calmette-Guerin Vaccine Players Market Share by Revenue
2.8.3 Global Bacille Calmette-Guerin Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bacille Calmette-Guerin Vaccine Market Scenario by Region
3.1 Global Bacille Calmette-Guerin Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Bacille Calmette-Guerin Vaccine Sales by Region: 2021–2032
3.2.1 Global Bacille Calmette-Guerin Vaccine Sales by Region: 2021–2026
3.2.2 Global Bacille Calmette-Guerin Vaccine Sales by Region: 2027–2032
3.3 Global Bacille Calmette-Guerin Vaccine Revenue by Region: 2021–2032
3.3.1 Global Bacille Calmette-Guerin Vaccine Revenue by Region: 2021–2026
3.3.2 Global Bacille Calmette-Guerin Vaccine Revenue by Region: 2027–2032
3.4 North America Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.4.1 North America Bacille Calmette-Guerin Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Bacille Calmette-Guerin Vaccine Sales by Country (2021–2032)
3.4.3 North America Bacille Calmette-Guerin Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.5.1 Europe Bacille Calmette-Guerin Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Bacille Calmette-Guerin Vaccine Sales by Country (2021–2032)
3.5.3 Europe Bacille Calmette-Guerin Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bacille Calmette-Guerin Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Bacille Calmette-Guerin Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Bacille Calmette-Guerin Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Bacille Calmette-Guerin Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.7.1 Latin America Bacille Calmette-Guerin Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Bacille Calmette-Guerin Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Bacille Calmette-Guerin Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Bacille Calmette-Guerin Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Bacille Calmette-Guerin Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bacille Calmette-Guerin Vaccine Sales by Type (2021–2032)
4.1.1 Global Bacille Calmette-Guerin Vaccine Sales by Type (2021–2026)
4.1.2 Global Bacille Calmette-Guerin Vaccine Sales by Type (2027–2032)
4.1.3 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Bacille Calmette-Guerin Vaccine Revenue by Type (2021–2032)
4.2.1 Global Bacille Calmette-Guerin Vaccine Revenue by Type (2021–2026)
4.2.2 Global Bacille Calmette-Guerin Vaccine Revenue by Type (2027–2032)
4.2.3 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Bacille Calmette-Guerin Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Bacille Calmette-Guerin Vaccine Sales by Application (2021–2032)
5.1.1 Global Bacille Calmette-Guerin Vaccine Sales by Application (2021–2026)
5.1.2 Global Bacille Calmette-Guerin Vaccine Sales by Application (2027–2032)
5.1.3 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Bacille Calmette-Guerin Vaccine Revenue by Application (2021–2032)
5.2.1 Global Bacille Calmette-Guerin Vaccine Revenue by Application (2021–2026)
5.2.2 Global Bacille Calmette-Guerin Vaccine Revenue by Application (2027–2032)
5.2.3 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Bacille Calmette-Guerin Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Bacille Calmette-Guerin Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Bacille Calmette-Guerin Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Japan BCG Lab
6.2.1 Japan BCG Lab Company Information
6.2.2 Japan BCG Lab Description and Business Overview
6.2.3 Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Japan BCG Lab Bacille Calmette-Guerin Vaccine Product Portfolio
6.2.5 Japan BCG Lab Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Company Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India Bacille Calmette-Guerin Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Serum Institute of India Bacille Calmette-Guerin Vaccine Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 AJ Vaccines
6.4.1 AJ Vaccines Company Information
6.4.2 AJ Vaccines Description and Business Overview
6.4.3 AJ Vaccines Bacille Calmette-Guerin Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 AJ Vaccines Bacille Calmette-Guerin Vaccine Product Portfolio
6.4.5 AJ Vaccines Recent Developments/Updates
6.5 BioFarma
6.5.1 BioFarma Company Information
6.5.2 BioFarma Description and Business Overview
6.5.3 BioFarma Bacille Calmette-Guerin Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BioFarma Bacille Calmette-Guerin Vaccine Product Portfolio
6.5.5 BioFarma Recent Developments/Updates
6.6 GreenSignal Bio Pharma
6.6.1 GreenSignal Bio Pharma Company Information
6.6.2 GreenSignal Bio Pharma Description and Business Overview
6.6.3 GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Product Portfolio
6.6.5 GreenSignal Bio Pharma Recent Developments/Updates
6.7 China National Biotec
6.7.1 China National Biotec Company Information
6.7.2 China National Biotec Description and Business Overview
6.7.3 China National Biotec Bacille Calmette-Guerin Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 China National Biotec Bacille Calmette-Guerin Vaccine Product Portfolio
6.7.5 China National Biotec Recent Developments/Updates
6.8 Biomed Lublin
6.8.1 Biomed Lublin Company Information
6.8.2 Biomed Lublin Description and Business Overview
6.8.3 Biomed Lublin Bacille Calmette-Guerin Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Biomed Lublin Bacille Calmette-Guerin Vaccine Product Portfolio
6.8.5 Biomed Lublin Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Company Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
6.10 Ataulpho de Paiva
6.10.1 Ataulpho de Paiva Company Information
6.10.2 Ataulpho de Paiva Description and Business Overview
6.10.3 Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Product Portfolio
6.10.5 Ataulpho de Paiva Recent Developments/Updates
6.11 IVAC – Institute of Vaccines and Medical Biologicals
6.11.1 IVAC – Institute of Vaccines and Medical Biologicals Company Information
6.11.2 IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
6.11.3 IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Product Portfolio
6.11.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
6.12 Queen Saovabha Mem. Inst
6.12.1 Queen Saovabha Mem. Inst Company Information
6.12.2 Queen Saovabha Mem. Inst Description and Business Overview
6.12.3 Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Product Portfolio
6.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
6.13 Microgen
6.13.1 Microgen Company Information
6.13.2 Microgen Description and Business Overview
6.13.3 Microgen Bacille Calmette-Guerin Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Microgen Bacille Calmette-Guerin Vaccine Product Portfolio
6.13.5 Microgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bacille Calmette-Guerin Vaccine Industry Chain Analysis
7.2 Bacille Calmette-Guerin Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bacille Calmette-Guerin Vaccine Production Mode & Process Analysis
7.4 Bacille Calmette-Guerin Vaccine Sales and Marketing
7.4.1 Bacille Calmette-Guerin Vaccine Sales Channels
7.4.2 Bacille Calmette-Guerin Vaccine Distributors
7.5 Bacille Calmette-Guerin Vaccine Customer Analysis
8 Bacille Calmette-Guerin Vaccine Market Dynamics
8.1 Bacille Calmette-Guerin Vaccine Industry Trends
8.2 Bacille Calmette-Guerin Vaccine Market Drivers
8.3 Bacille Calmette-Guerin Vaccine Market Challenges
8.4 Bacille Calmette-Guerin Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Japan BCG Lab
China National Biotec
Serum Institute of India
AJ Vaccines
Biofarma
GreenSignal Bio Pharma
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
List of Tables
 Table 1. Global Bacille Calmette-Guerin Vaccine Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Bacille Calmette-Guerin Vaccine Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Bacille Calmette-Guerin Vaccine Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Bacille Calmette-Guerin Vaccine Sales (K Dose) of Key Manufacturers (2021–2026)
 Table 5. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Bacille Calmette-Guerin Vaccine Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Bacille Calmette-Guerin Vaccine Average Price (US$/Dose) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Bacille Calmette-Guerin Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Product Types and Applications
 Table 12. Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Bacille Calmette-Guerin Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Bacille Calmette-Guerin Vaccine Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Bacille Calmette-Guerin Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Bacille Calmette-Guerin Vaccine Sales by Region (K Dose), 2021–2026
 Table 18. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2021–2026)
 Table 19. Global Bacille Calmette-Guerin Vaccine Sales by Region (K Dose), 2027–2032
 Table 20. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2027–2032)
 Table 21. Global Bacille Calmette-Guerin Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2021–2026)
 Table 23. Global Bacille Calmette-Guerin Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2027–2032)
 Table 25. North America Bacille Calmette-Guerin Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Bacille Calmette-Guerin Vaccine Sales by Country (K Dose), 2021–2026
 Table 27. North America Bacille Calmette-Guerin Vaccine Sales by Country (K Dose), 2027–2032
 Table 28. North America Bacille Calmette-Guerin Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Bacille Calmette-Guerin Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Bacille Calmette-Guerin Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Bacille Calmette-Guerin Vaccine Sales by Country (K Dose), 2021–2026
 Table 32. Europe Bacille Calmette-Guerin Vaccine Sales by Country (K Dose), 2027–2032
 Table 33. Europe Bacille Calmette-Guerin Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Bacille Calmette-Guerin Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Bacille Calmette-Guerin Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Bacille Calmette-Guerin Vaccine Sales by Region (K Dose), 2021–2026
 Table 37. Asia Pacific Bacille Calmette-Guerin Vaccine Sales by Region (K Dose), 2027–2032
 Table 38. Asia Pacific Bacille Calmette-Guerin Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Bacille Calmette-Guerin Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Bacille Calmette-Guerin Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Bacille Calmette-Guerin Vaccine Sales by Country (K Dose), 2021–2026
 Table 42. Latin America Bacille Calmette-Guerin Vaccine Sales by Country (K Dose), 2027–2032
 Table 43. Latin America Bacille Calmette-Guerin Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Bacille Calmette-Guerin Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Bacille Calmette-Guerin Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Country (K Dose), 2021–2026
 Table 47. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Country (K Dose), 2027–2032
 Table 48. Middle East and Africa Bacille Calmette-Guerin Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Bacille Calmette-Guerin Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Bacille Calmette-Guerin Vaccine Sales (K Dose) by Type (2021–2026)
 Table 51. Global Bacille Calmette-Guerin Vaccine Sales (K Dose) by Type (2027–2032)
 Table 52. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2021–2026)
 Table 53. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2027–2032)
 Table 54. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2021–2026)
 Table 57. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2027–2032)
 Table 58. Global Bacille Calmette-Guerin Vaccine Price (US$/Dose) by Type (2021–2026)
 Table 59. Global Bacille Calmette-Guerin Vaccine Price (US$/Dose) by Type (2027–2032)
 Table 60. Global Bacille Calmette-Guerin Vaccine Sales (K Dose) by Application (2021–2026)
 Table 61. Global Bacille Calmette-Guerin Vaccine Sales (K Dose) by Application (2027–2032)
 Table 62. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2021–2026)
 Table 63. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2027–2032)
 Table 64. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2021–2026)
 Table 67. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2027–2032)
 Table 68. Global Bacille Calmette-Guerin Vaccine Price (US$/Dose) by Application (2021–2026)
 Table 69. Global Bacille Calmette-Guerin Vaccine Price (US$/Dose) by Application (2027–2032)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 73. Merck Bacille Calmette-Guerin Vaccine Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Japan BCG Lab Company Information
 Table 76. Japan BCG Lab Description and Business Overview
 Table 77. Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 78. Japan BCG Lab Bacille Calmette-Guerin Vaccine Product
 Table 79. Japan BCG Lab Recent Developments/Updates
 Table 80. Serum Institute of India Company Information
 Table 81. Serum Institute of India Description and Business Overview
 Table 82. Serum Institute of India Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 83. Serum Institute of India Bacille Calmette-Guerin Vaccine Product
 Table 84. Serum Institute of India Recent Developments/Updates
 Table 85. AJ Vaccines Company Information
 Table 86. AJ Vaccines Description and Business Overview
 Table 87. AJ Vaccines Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 88. AJ Vaccines Bacille Calmette-Guerin Vaccine Product
 Table 89. AJ Vaccines Recent Developments/Updates
 Table 90. BioFarma Company Information
 Table 91. BioFarma Description and Business Overview
 Table 92. BioFarma Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 93. BioFarma Bacille Calmette-Guerin Vaccine Product
 Table 94. BioFarma Recent Developments/Updates
 Table 95. GreenSignal Bio Pharma Company Information
 Table 96. GreenSignal Bio Pharma Description and Business Overview
 Table 97. GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 98. GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Product
 Table 99. GreenSignal Bio Pharma Recent Developments/Updates
 Table 100. China National Biotec Company Information
 Table 101. China National Biotec Description and Business Overview
 Table 102. China National Biotec Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 103. China National Biotec Bacille Calmette-Guerin Vaccine Product
 Table 104. China National Biotec Recent Developments/Updates
 Table 105. Biomed Lublin Company Information
 Table 106. Biomed Lublin Description and Business Overview
 Table 107. Biomed Lublin Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 108. Biomed Lublin Bacille Calmette-Guerin Vaccine Product
 Table 109. Biomed Lublin Recent Developments/Updates
 Table 110. Taj Pharmaceuticals Company Information
 Table 111. Taj Pharmaceuticals Description and Business Overview
 Table 112. Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 113. Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Product
 Table 114. Taj Pharmaceuticals Recent Developments/Updates
 Table 115. Ataulpho de Paiva Company Information
 Table 116. Ataulpho de Paiva Description and Business Overview
 Table 117. Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 118. Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Product
 Table 119. Ataulpho de Paiva Recent Developments/Updates
 Table 120. IVAC – Institute of Vaccines and Medical Biologicals Company Information
 Table 121. IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
 Table 122. IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 123. IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Product
 Table 124. IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
 Table 125. Queen Saovabha Mem. Inst Company Information
 Table 126. Queen Saovabha Mem. Inst Description and Business Overview
 Table 127. Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 128. Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Product
 Table 129. Queen Saovabha Mem. Inst Recent Developments/Updates
 Table 130. Microgen Company Information
 Table 131. Microgen Description and Business Overview
 Table 132. Microgen Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 133. Microgen Bacille Calmette-Guerin Vaccine Product
 Table 134. Microgen Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Bacille Calmette-Guerin Vaccine Distributors List
 Table 138. Bacille Calmette-Guerin Vaccine Customers List
 Table 139. Bacille Calmette-Guerin Vaccine Market Trends
 Table 140. Bacille Calmette-Guerin Vaccine Market Drivers
 Table 141. Bacille Calmette-Guerin Vaccine Market Challenges
 Table 142. Bacille Calmette-Guerin Vaccine Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Bacille Calmette-Guerin Vaccine
 Figure 2. Global Bacille Calmette-Guerin Vaccine Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Bacille Calmette-Guerin Vaccine Market Share by Type: 2025 & 2032
 Figure 4. Immune Vaccine Product Picture
 Figure 5. Therapy Vaccine Product Picture
 Figure 6. Global Bacille Calmette-Guerin Vaccine Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Bacille Calmette-Guerin Vaccine Market Share by Application: 2025 & 2032
 Figure 8. Self-Procurement
 Figure 9. UNICEF
 Figure 10. Other
 Figure 11. Global Bacille Calmette-Guerin Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Bacille Calmette-Guerin Vaccine Market Size (US$ Million), 2021–2032
 Figure 13. Global Bacille Calmette-Guerin Vaccine Sales (K Dose), 2021–2032
 Figure 14. Global Bacille Calmette-Guerin Vaccine Average Price (US$/Dose), 2021–2032
 Figure 15. Bacille Calmette-Guerin Vaccine Report Years Considered
 Figure 16. Bacille Calmette-Guerin Vaccine Sales Share by Manufacturers in 2025
 Figure 17. Global Bacille Calmette-Guerin Vaccine Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Bacille Calmette-Guerin Vaccine Players: Market Share by Revenue in Bacille Calmette-Guerin Vaccine in 2025
 Figure 19. Bacille Calmette-Guerin Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Bacille Calmette-Guerin Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2021–2032)
 Figure 22. North America Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2021–2032)
 Figure 23. United States Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2021–2032)
 Figure 26. Europe Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2021–2032)
 Figure 34. China Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Bacille Calmette-Guerin Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Bacille Calmette-Guerin Vaccine by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Bacille Calmette-Guerin Vaccine by Type (2021–2032)
 Figure 55. Global Bacille Calmette-Guerin Vaccine Price (US$/Dose) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Bacille Calmette-Guerin Vaccine by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Bacille Calmette-Guerin Vaccine by Application (2021–2032)
 Figure 58. Global Bacille Calmette-Guerin Vaccine Price (US$/Dose) by Application (2021–2032)
 Figure 59. Bacille Calmette-Guerin Vaccine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global BCG and Tuberculosis Vaccine Market Research Report 2025
Global BCG Vaccination Market Research Report 2025
Global Bacillus Calmette Guerin Vaccine Market Research Report 2025
Global BCG Vaccine Market Insights Forecast to 2030
Global Tuberculosis Vaccination Market Research Report 2025
TB Vaccine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BCG Tuberculosis TB Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global BCG Vaccine for Tuberculosis TB Market Research Report 2025
VPM1002 Tuberculosis BCG Based Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global TB Disease Vaccine Market Research Report 2025
Tuberculosis Prevention and Treatment Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global TB Vaccines Market Insights Forecast to 2030
Bacille Calmette Guérin Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravesical Bacillus Calmette Market Research Report 2024
Global Tuberculosis Vaccine for Vhildren Market Research Report 2024
Global Antibacterial Vaccines Market Research Report 2024
Global Tuberculosis Vaccines Market Research Report 2024
Global Therapeutic BCG Vaccines Market Insights Forecast to 2030
Global BCG Vaccine for Intradermal Injection Market Research Report 2024
Tuberculosis Vaccine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions